II, in sera from cancer patients stimulated interest among investigators with the prospect of developing a serological test for the detection of cancer (8) . Subsequently, Podolsky and Weiser (9) were able to separate and purify the galactosyltransferases, GT I and GT II, from malignant effusion and determined that they possessed the same enzymic properties as did their counterparts detected in serum samples. The present report describes our findings of a unique GT variant, which is distinct from GT I and GT II, in pleural effusions of patients with malignant diseases and some patients with benign disorders. Oxnard, CA 93030), packed with 10 to 11 mL of DEAE-cellulose, and rinsed with 5 to 6 mL of low-salt buffer. After application of 1.5 to 2.0 mL of the pretreated sample, we eluted the column by applying 1 mL of low-salt buffer to the top of the column. Each 1-mL fraction was collected at the flow rate of 1 mL/12 mm by manually shifting the test tube rack. The fractions contained, per liter, 40 mmol of N-acetyl-D-glucosamine and 4 g of bovine serum albumin (final concentrations) as enzyme stabilizers. In the usual screening experiment, we collected a total of 24 fractions and measured GT activity by the method of Baxter and Durham (10) . Glycoprotein acceptor in this study was fetuin without terminal sialic acid and the penultimate galactose residue. 
Materials and Methods

Materials
Polyacrylamide gel electrophoresis.
For polyacrylamide gel electrophoresis we used a modification of the method of Podolsky and Weiser (8) . A 35-iL sample was directly applied to the gel and electrophoresed until the albumin-dye marker had migrated 55 to 60 mm from the origin. The gel was then sliced at 2.0-mm intervals and each slice was transferred into a tube containing 100 /LL of a mixture containing, per liter, 0.1 mol of sodium cacodylate, 20 mmol of N-acetyl-D-glucosamine, and 4 g of bovine serum albumin.
The tubes were incubated overnight at 4 #{176}C, and the eluents were assayed for GT activity. 
Results and Discussion
We measured total galactosyltransferase activity of pleural effusion specimens from patients with various benign disorders or malignant neoplastic diseases, using asialo-agalacto fetuin as the acceptor.
We found the mean value of total GT activity in pleural effusion to be slightly higher in patients with carcinoma than in those with benign diseases (Figure 1 ), but the increase was not statistically significant.
When we chromatographed a specimen of pleural effusion from a patient with colon carcinoma on DEAE-cellulose, a small band of GT activity emerged during the washing with low-salt buffer (Figure 2 ). The appearance of this GT band was reproducible, and it was distinctly separated from other GT bands. Hence, the GT enzyme eluted with the buffer of low ionic strength was termed GT(l). Subsequent application of a linear salt gradient between the low-salt (0.5 mmol/L) and high-salt (0.1 mollL) concentrations eluted major GT bands, which we designated "GT(h)." The GT(h) bands were present in all pleural effusions examined, but the GT(l) band was frequently absent in specimens from patients with non-malignant diseases. Therefore, in the mini-column procedure the GT(h) enzymes were not eluted from the column. Figure 3 illustrates elution profiles of the GT enzymes in two specimens of pleural effusion processed by the mini-column method. The first peak (Peak 1) emerged in the early fractions and showed variation with a change in the sample volume. There appeared to be no direct quantitative relationship between Peak 1 and GT(l) bands. The polyacrylamide gel electropherogram profile ( Figure 4) indicates that Peak 1 in Figures 2 and 3 resulted from overloading the columns. An excessive amount of sample was applied in the mini-column method, so that even a relatively small proportion of GT (1) enzyme in a specimen could be detected, although this was not necessary in the case of some specimens for GT(l) enzyme to be apparent (see Figure   2 ).
From the apparent GT activities manifested in the elution profile, we estimated the contribution by GT(1) enzyme to be less than 3% of the total GT activity in the GT(1)-containing specimens. The GT(l) enzyme quickly lost enzyme activity after separation from GT(h) and the other constituents of pleural effusion. Therefore, any value found for GT(l) enzyme activity must be a minimum value for that sample.
Podolsky and Weiser (9) fractionated galactosyltransferases, GT I and GT II, using DEAE-cellulose and two additional affinity column chromatography techniques. However, they probably did not see GT (1) enzyme in the eluates from their DEAE-column, because GT(1) is eluted at a lower salt concentration than is required for elution of either GT I or GT II. In our study, GT I and GT II evidently correspond to our GT(h) bands.
In a study of 26 specimens obtained from cancer patients, 19 demonstrated GT(1) activity, whereas only eight of 25 specimens from patients with non-malignant diseases did so (Table 1) . We saw no direct correlation between the total GT activity and the presence of GT(l) enzymes in the pleural effusions. If a GT activity of 105 units/25 L is regarded as the cutoff value in Figure 1 , 13 of 21 specimens with a high value for total GT and 14 of 30 specimens with a low value for total GT exhibited the presence of GT(1) enzymes. We also measured the total protein in the specimens (103, SD 33 gIL) and found that 19 of 30 specimens with high protein content (>103 gIL) as well as nine of 22 specimens with low protein content (<103 gIL) gave positive results for GT (1) . These results indicate that the detection of GT (1) in specimens of pleural effusion is directly related to neither total GT activity nor total protein content.
Molecular characterization of the isolated GT(1) enzyme has been hampered by its instability. Nevertheless, Figure 4 compares the electrophoretic migration patterns of the GT enzymes in the original pleural effusion, Peak 1, GT(l), and and also demonstrates that the enzymes migrate considerably slower than do the GT(h) species.
In this regard, the electrophoretic properties of GT(l) enzyme resemble those of the cancer-associated GT II. Although the origin and relation of GT (1) enzyme to other GT species are not known, our results seem to suggest that the production of the GT(1) enzyme may be restricted to physiological conditions occurring during the development of malignant diseases and certain other abnormalities.
